文献速递儿科与产科急症重症综合管理与镇静镇痛

儿科心理健康相关急诊医疗服务就诊中需胃肠外镇静的急性严重行为障碍:回顾性病历审查

Acute Severe Behavioral Disturbance Requiring Parenteral Sedation in Pediatric Mental Health Presentations to Emergency Medical Services: A Retrospective Chart Review.
PubMed 文献 · Ann Emerg Med · 2023-06-30
一句话结论在澳大利亚全州EMS系统中,儿科心理健康就诊占14%,其中8%因急性严重行为障碍接受胃肠外镇静,咪达唑仑为首选(75%),无严重不良事件。

该研究回顾性审查2018年7月至2019年6月澳大利亚一个覆盖650万人口的全州EMS系统记录,纳入18岁以下心理健康相关就诊的年轻患者。共7,816例,中位年龄15岁(IQR 14-17),60%为女性,占所有儿科EMS就诊的14%。612例(8%)因急性严重行为障碍接受胃肠外镇静,其中460例(75%)首选咪达唑仑,152例(25%)使用氯胺酮。自闭症谱系障碍(OR 3.3;CI 2.7-3.9)、创伤后应激障碍(OR 2.8;CI 2.2-3.5)和智力障碍(OR 3.6;CI 2.6-4.8)与接受胃肠外镇静的 odds 增加相关。未记录到严重不良事件。

要点

  • 儿科心理健康相关EMS就诊占所有儿科EMS就诊的14%,其中8%(612/7816)因急性严重行为障碍接受胃肠外镇静。
  • 自闭症谱系障碍(OR 3.3;CI 2.7-3.9)、创伤后应激障碍(OR 2.8;CI 2.2-3.5)和智力障碍(OR 3.6;CI 2.6-4.8)与接受胃肠外镇静的 odds 增加相关。
  • 在接受胃肠外镇静的年轻患者中,75%(460例)首选咪达唑仑,25%(152例)使用氯胺酮。
  • 未记录到严重不良事件,提示在院外环境中镇静似乎总体安全。

适用人群与场景

  • 18岁以下(aged <18 years)的年轻患者,因心理健康相关问题就诊于澳大利亚全州EMS系统
  • 研究期间为2018年7月至2019年6月,覆盖人口650万

处置流程与药物剂量

  • 对急性严重行为障碍的年轻患者,胃肠外镇静首选咪达唑仑(460/612,75%),其余使用氯胺酮(152/612,25%)

研究设计与关键结果

  • 研究类型为回顾性病历审查,纳入7,816例心理健康相关EMS就诊的年轻患者,中位年龄15岁(IQR 14-17),60%为女性,占所有儿科EMS就诊的14%。
  • 612例(8%)因急性严重行为障碍接受胃肠外镇静;自闭症谱系障碍(OR 3.3;CI 2.7-3.9)、创伤后应激障碍(OR 2.8;CI 2.2-3.5)和智力障碍(OR 3.6;CI 2.6-4.8)与接受胃肠外镇静的 odds 增加相关。
  • 在接受胃肠外镇静的患者中,460例(75%)首选咪达唑仑,152例(25%)使用氯胺酮;未记录到严重不良事件。

证据类型、等级与局限

  • 证据类型:回顾性病历审查;局限:原文未报告局限性。

对床旁实践的改变

  • 在院外环境中,对急性严重行为障碍的年轻患者使用胃肠外镇静似乎总体安全,咪达唑仑为最常用的一线药物(460/612,75%),氯胺酮用于其余患者(152/612,25%)。
  • 有自闭症谱系障碍、创伤后应激障碍或智力障碍病史的年轻心理健康患者,接受胃肠外镇静的 odds 更高(OR 分别为3.3、2.8、3.6),临床中可能更需评估行为障碍的严重程度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVES: To describe the epidemiological factors of mental health presentations in young people to emergency medical services (EMS) and define those experiencing acute severe behavioral disturbance by reviewing parenteral sedation use.

METHODS: We performed a retrospective review of records of EMS attendance for young people (aged <18 years) with mental health presentations between July 2018 and June 2019 to a statewide EMS system in Australia of a population of 6.5 million persons. In addition, epidemiological data and information about parenteral sedation for acute severe behavioral disturbance and any adverse events were extracted from the records and analyzed.

RESULTS: A total of 7,816 patients had mental health presentations with a median age of 15 years (IQR 14-17). The majority (60%) were female. These presentations accounted for 14% of all pediatric presentations to EMS. Out of them, 612 (8%) received parenteral sedation for acute severe behavioral disturbance. A number of factors were associated with increased odds of parenteral sedative medication being used, including autism spectrum disorder (odds ratio [OR] 3.3; confidence interval [CI], 2.7 to 3.9), posttraumatic stress disorder (OR 2.8; CI, 2.2 to 3.5) and intellectual disability (OR 3.6; CI, 2.6 to 4.8). The majority (460, 75%) of young people received midazolam as their first-line medication, with the remaining patients being provided ketamine (152, 25%). No serious adverse events were noted.

CONCLUSION: Mental health conditions were a common presentation to EMS. A history of autism spectrum disorder, posttraumatic stress disorder, or an intellectual disability increased the odds of receiving parenteral sedation for acute severe behavioral disturbance. Sedation appears generally safe in the out-of-hospital setting.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bourke EM, Douglas N, Wilson CL, et al. Acute Severe Behavioral Disturbance Requiring Parenteral Sedation in Pediatric Mental Health Presentations to Emergency Medical Services: A Retrospective Chart Review. Ann Emerg Med. 2023. PMID: 37389492. doi:10.1016/j.annemergmed.2023.04.028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。